Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Marker Therapeutics, Inc. - Common Stock (NQ:MRKR)

1.560 +0.060 (+4.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 208,236
Open 1.500
Bid (Size) 1.500 (2)
Ask (Size) 1.530 (1)
Prev. Close 1.500
Today's Range 1.465 - 1.560
52wk Range 0.9500 - 5.950
Shares Outstanding 8,923,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Here are the top movers in Thursday's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
-50.9%
-50.9%
1 Month
+4.7%
+4.7%
3 Month
+24.8%
+24.8%
6 Month
-27.1%
-27.1%
1 Year
-70.5%
-70.5%

More News

Read More
Gapping stocks in Thursday's session
Via Chartmill
Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Which stocks have an unusual volume on Monday?
Via Chartmill
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
MRKR Stock Earnings: Marker Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q1 2024
Via InvestorPlace
Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 12/11
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?
Via Benzinga
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies
Via Newsfile
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
Via Benzinga

Frequently Asked Questions

Is Marker Therapeutics, Inc. - Common Stock publicly traded?
Yes, Marker Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Marker Therapeutics, Inc. - Common Stock trade on?
Marker Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Marker Therapeutics, Inc. - Common Stock?
The ticker symbol for Marker Therapeutics, Inc. - Common Stock is MRKR on the Nasdaq Stock Market
What is the current price of Marker Therapeutics, Inc. - Common Stock?
The current price of Marker Therapeutics, Inc. - Common Stock is 1.560
When was Marker Therapeutics, Inc. - Common Stock last traded?
The last trade of Marker Therapeutics, Inc. - Common Stock was at 07/25/25 04:00 PM ET
What is the market capitalization of Marker Therapeutics, Inc. - Common Stock?
The market capitalization of Marker Therapeutics, Inc. - Common Stock is 13.92M
How many shares of Marker Therapeutics, Inc. - Common Stock are outstanding?
Marker Therapeutics, Inc. - Common Stock has 14M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.